- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04385914
Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital
May 11, 2020 updated by: Farah Benarba, Atlantic Health System
Demographics and Outcomes of Pregnant COVID 19 Positive Women in a Community Health System
Demographics of pregnant COVID persons under investigation and those who were positive from March-May 2020.
Looking at demographics including age, socio-economic status and pregnancy outcomes in these groups.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Samantha Collazo, MD
- Phone Number: 856-397-7788
- Email: samantha.collazo@atlantichealth.org
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Pregnant patients who presented to AHS within March-May 2020
Description
Inclusion Criteria:
- Currently pregnant, considered PUI or know COVID positive patient during pregnancy, and documentation of COVID symptoms within AHS.
Exclusion Criteria:
- Not pregnant, No documentation of COVID-19 symptoms within AHS.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
COVID positive patients
|
Following pregnancy outcomes whether they are COVID positive or negative
|
COVID negative patients
|
Following pregnancy outcomes whether they are COVID positive or negative
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pregnancy Outcome
Time Frame: through study completion, approximately 1 year
|
increased risk of preterm birth, preeclampsia, etc.
|
through study completion, approximately 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
May 1, 2020
Primary Completion (Anticipated)
September 1, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
May 11, 2020
First Submitted That Met QC Criteria
May 11, 2020
First Posted (Actual)
May 13, 2020
Study Record Updates
Last Update Posted (Actual)
May 13, 2020
Last Update Submitted That Met QC Criteria
May 11, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1595116-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corona Virus Infection
-
Ain Shams UniversityMisr International UniversityCompletedCorona Virus Infection | Corona Virus Disease 19 (Covid19) | Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2)Egypt
-
Montreal Heart InstituteNational Heart, Lung, and Blood Institute (NHLBI); Bill and Melinda Gates Foundation and other collaboratorsTerminatedCorona Virus InfectionSpain, United States, Canada, Brazil, Greece, South Africa
-
Fundación Instituto de Estudios de Ciencias de...Instituto de Investigación Biomédica de SalamancaTerminated
-
ANRS, Emerging Infectious DiseasesSciences Economiques et Sociales de la Santé & Traitement de l'Information... and other collaboratorsWithdrawn
-
National Institute of Allergy and Infectious Diseases...CompletedCorona Virus InfectionUnited States
-
The Cleveland ClinicCompletedCOVID | Corona Virus InfectionUnited States
-
NeurognosUnknownCOVID | Corona Virus Infection | SARS-CoV2Chile
-
Chronic Obstructive Pulmonary Disease Trial Network...TerminatedVirus Diseases | Corona Virus Infection | Infection ViralDenmark
-
University of Sao PauloMaria Aparecida de Andrade Moreira Machado; Thais Marchini de Oliveira ValarelliNot yet recruitingCorona Virus Infection | Exposure During Pregnancy
-
National Research Center for Cardiac Surgery, KazakhstanNazarbayev University Medical CenterRecruitingCovid19 | Corona Virus InfectionKazakhstan
Clinical Trials on COVID positive via testing
-
Inova Health Care ServicesCompletedPregnancy Related | Corona Virus InfectionUnited States
-
Hasanuddin UniversityChulalongkorn UniversityCompleted
-
Duke UniversityNorth Carolina Department of Health and Human ServicesCompleted
-
San Diego State UniversityNational Cancer Institute (NCI)Recruiting
-
University of Campania "Luigi Vanvitelli"UnknownCovid19 | Placenta Diseases | Preterm Birth | Miscarriage | SARS-CoV Infection | Obstetric ComplicationItaly
-
San Diego State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
Duke UniversityCompletedCovid19United States
-
Rush University Medical CenterCompletedCOVID-19 PandemicUnited States
-
Pinnacle Health Cardiovascular InstituteUnknownCorona Virus InfectionUnited States
-
Rolfs Consulting und Verwaltungs-GmbH (RCV)Rhythm Pharmaceuticals, Inc.RecruitingCognitive Impairment | Hyperphagia | Obesity, Childhood | Bardet-Biedl Syndrome | Polydactyly | Retinopathy | Syndactyly | POMC DeficiencyGermany